Roberto Ruiz-Cordero, MD, FASCP, is an associate professor of Pathology at the University of Miami Miller School of Medicine. Before that, he served on the faculty in the Cytopathology Department at the University of California, San Francisco. He was recruited back by the University of Miami to join its faculty as associate director of Cytopathology to develop the University’s division of Molecular Cytopathology. He is actively consulted on cytology cases of hematolymphoid malignancies and has expertise in developing and signing out next-generation sequencing assays. His research interests extend across three different fields including molecular cytopathology, where he implements novel workflows and assays using cytology samples, global cancer where he works to improve cancer diagnostics in resource-constrained settings to address health care disparities, and hematopathology where, as an active member of the Cyto-Heme Diagnostic Inter-Institutional Collaborative (CHIC), he focuses on generating evidence-based guidelines for the use of small specimens in lymphoma diagnostics. He completed residency in anatomic and clinical pathology at Jackson Memorial Hospital in Miami, followed by fellowships in cytopathology, molecular genetics pathology, and hematopathology at MD Anderson Cancer Center in Houston.
